Company profile SNDX
After 39 days of this quarter the interest is at 35.0. Based on that we can calculate that during remaining 52 days it will total up to 82.0. Syndax Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-50.3%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 83 | 75 -9.6% QoQ | 96 28.0% QoQ | 29 -69.8% QoQ |
| 2020 | 78 -6.0% YoY 169.0% QoQ | 230 206.7% YoY 194.9% QoQ | 33 -65.6% YoY -85.7% QoQ | 45 55.2% YoY 36.4% QoQ |
| 2021 | 29 -62.8% YoY -35.6% QoQ | 157 -31.7% YoY 441.4% QoQ | 90 172.7% YoY -42.7% QoQ | 88 95.6% YoY -2.2% QoQ |
| 2022 | 33 13.8% YoY -62.5% QoQ | 89 -43.3% YoY 169.7% QoQ | 71 -21.1% YoY -20.2% QoQ | 76 -13.6% YoY 7.0% QoQ |
| 2023 | 165 400.0% YoY 117.1% QoQ | 128 43.8% YoY -22.4% QoQ | 87 22.5% YoY -32.0% QoQ | 96 26.3% YoY 10.3% QoQ |
| 2024 | 35 -78.8% YoY -63.5% QoQ | - | - | - |
The average 5 years interest of Syndax Pharmaceuticals was 6.95 per week. The last year interest of Syndax Pharmaceuticals compared to the last 5 years has changed by 28.35%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 54.06%.
After 39 days of this quarter the interest is at 51.0. Based on that we can calculate that during remaining 52 days it will total up to 119.0. SNDX stock price expected interest is significantly higher compared to previous quarter (+271.9%) and same quarter last year (+271.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 58 | 151 160.3% QoQ | 97 -35.8% QoQ | 71 -26.8% QoQ |
| 2020 | 137 136.2% YoY 93.0% QoQ | 112 -25.8% YoY -18.2% QoQ | 104 7.2% YoY -7.1% QoQ | 104 46.5% YoY 0.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 166 48.2% YoY inf% QoQ | 40 -61.5% YoY -75.9% QoQ | 69 -33.7% YoY 72.5% QoQ |
| 2022 | 75 inf% YoY 8.7% QoQ | 159 -4.2% YoY 112.0% QoQ | 101 152.5% YoY -36.5% QoQ | 190 175.4% YoY 88.1% QoQ |
| 2023 | 32 -57.3% YoY -83.2% QoQ | 90 -43.4% YoY 181.2% QoQ | 94 -6.9% YoY 4.4% QoQ | 32 -83.2% YoY -66.0% QoQ |
| 2024 | 51 59.4% YoY 59.4% QoQ | - | - | - |
The average 5 years interest of SNDX stock price was 7.41 per week. The last year interest of SNDX stock price compared to the last 5 years has changed by -30.77%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -44.9%.
After 39 days of this quarter the interest is at 55.0. Based on that we can calculate that during remaining 52 days it will total up to 128.0. SNDX news expected interest is significantly higher compared to previous quarter (+109.8%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 130 inf% QoQ | 63 -51.5% QoQ | 41 -34.9% QoQ |
| 2020 | 68 inf% YoY 65.9% QoQ | 148 13.8% YoY 117.6% QoQ | 148 134.9% YoY 0.0% QoQ | 111 170.7% YoY -25.0% QoQ |
| 2021 | 27 -60.3% YoY -75.7% QoQ | 139 -6.1% YoY 414.8% QoQ | 94 -36.5% YoY -32.4% QoQ | 77 -30.6% YoY -18.1% QoQ |
| 2022 | 80 196.3% YoY 3.9% QoQ | 61 -56.1% YoY -23.8% QoQ | 71 -24.5% YoY 16.4% QoQ | 52 -32.5% YoY -26.8% QoQ |
| 2023 | 157 96.2% YoY 201.9% QoQ | 50 -18.0% YoY -68.2% QoQ | 249 250.7% YoY 398.0% QoQ | 61 17.3% YoY -75.5% QoQ |
| 2024 | 55 -65.0% YoY -9.8% QoQ | - | - | - |
The average 5 years interest of SNDX news was 7.21 per week. The last year interest of SNDX news compared to the last 5 years has changed by 29.68%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 84.78%.
There is not enough data for SNDX clinical trials to provide analysis
There is not enough data for SNDX clinical trials to provide correlation calculation
There is not enough data for SNDX clinical trials to provide analysis
There is not enough data for SNDX cancer therapies to provide analysis
There is not enough data for SNDX cancer therapies to provide correlation calculation
There is not enough data for SNDX cancer therapies to provide analysis
There is not enough data for SNDX Menin inhibitor to provide analysis
There is not enough data for SNDX Menin inhibitor to provide correlation calculation
There is not enough data for SNDX Menin inhibitor to provide analysis
There is not enough data for SNDX CSF-1 receptor inhibitor to provide analysis
There is not enough data for SNDX CSF-1 receptor inhibitor to provide correlation calculation
There is not enough data for SNDX CSF-1 receptor inhibitor to provide analysis
There is not enough data for SNDX Entinostat development to provide analysis
There is not enough data for SNDX Entinostat development to provide correlation calculation
There is not enough data for SNDX Entinostat development to provide analysis
There is not enough data for SNDX headquarters to provide analysis
There is not enough data for SNDX headquarters to provide correlation calculation
There is not enough data for SNDX headquarters to provide analysis
There is not enough data for Syndax Pharmaceuticals CEO to provide analysis
There is not enough data for Syndax Pharmaceuticals CEO to provide correlation calculation
There is not enough data for Syndax Pharmaceuticals CEO to provide analysis